123 related articles for article (PubMed ID: 1478435)
1. [Heterogeneity of immunologic subtypes of blast crisis in chronic myeloid leukemia].
Frolov EA; Baryshnikov AIu; Moiseenkova IN; Tupitsyn NN; Turkina AG
Gematol Transfuziol; 1992; 37(5-6):6-10. PubMed ID: 1478435
[TBL] [Abstract][Full Text] [Related]
2. Immunophenotype and ultrastructural studies in blast crisis of chronic myeloid leukemia.
Nair C; Chopra H; Shinde S; Barbhaya S; Kumar A; Dhond S; Yejamanam B; Sapre R; Chougule A; Advani S
Leuk Lymphoma; 1995 Oct; 19(3-4):309-13. PubMed ID: 8535224
[TBL] [Abstract][Full Text] [Related]
3. Burkitt-like blast crisis in chronic myeloid leukemia.
Colovic M; Jankovic G; Lazarevic V
Med Oncol; 1996 Jun; 13(2):119-20. PubMed ID: 9013475
[TBL] [Abstract][Full Text] [Related]
4. [A "primitive" variant of the blast crisis in chronic myeloleukemia].
Baryshnikov AIu; Turkina AG; Moiseenkova IN; Frolova EA; Sediakhina NP; Diagileva OA; Khoroshko ND; Mokeeva RA
Ter Arkh; 1995; 67(7):22-5. PubMed ID: 7482298
[TBL] [Abstract][Full Text] [Related]
5. Immunophenotypic characteristics of the blast crisis in chronic myeloid leukemia.
López-Karpovitch X; Cárdenas R; Piedras J
Rev Invest Clin; 1997; 49(1):31-6. PubMed ID: 9229753
[TBL] [Abstract][Full Text] [Related]
6. [Expression of primitive stem cell antigens on the blast cells of patients with chronic myeloid leukemia].
Baryshnikov AIu
Vestn Ross Akad Med Nauk; 1996; (3):9-13. PubMed ID: 8672965
[TBL] [Abstract][Full Text] [Related]
7. [Immunophenotype of blast crisis in chronic myeloid leukemia].
Favre G; Passweg J; Hoffmann T; Speck B; Gratwohl A; Tichelli A
Schweiz Med Wochenschr; 1998 Oct; 128(42):1624-6. PubMed ID: 9824896
[TBL] [Abstract][Full Text] [Related]
8. Immunophenotypic characteristics of blast crisis of chronic myeloid leukaemia: correlations with clinico-biological features and survival.
Urbano-Ispizua A; Cervantes F; Matutes E; Villamor N; Pujades A; Sierra J; Feliu E; Vives-Corrons JL; Montserrat E; Rozman C
Leukemia; 1993 Sep; 7(9):1349-54. PubMed ID: 8371586
[TBL] [Abstract][Full Text] [Related]
9. Enhanced NK activity during blast crisis in chronic myelogenous leukemia (CML).
Delwail V; Meseri A; Brizard A; Lecron JC; Sadoun A; Costerousse F; Guilhot F; Tanzer J; Goube de Laforest P
Leuk Res; 1992; 16(6-7):721-2. PubMed ID: 1635387
[No Abstract] [Full Text] [Related]
10. [Immunogenotypes and surface marker analysis in Ph1 positive chronic myelogenous leukemia in the blastic crisis].
Ohyashiki JH; Kawakubo K; Murakami T; Toyama K
Nihon Rinsho; 1992 Jun; 50(6):1262-6. PubMed ID: 1518143
[TBL] [Abstract][Full Text] [Related]
11. [Blast crisis of chronic myelogenous leukemia with blasts expressing both immature B lymphocyte- and myelomonocyte-associated antigens and differentiating into basophils in vitro].
Utsunomiya Y; Iwamasa K; Yasukawa M; Tamai T; Shiosaka T; Bando S
Rinsho Ketsueki; 1990 Jul; 31(7):1017-21. PubMed ID: 2214182
[TBL] [Abstract][Full Text] [Related]
12. CD33, CD4-double positive blastic transformation in a patient with chronic myelogenous leukemia.
Hirayama Y; Kohgo Y; Kanisawa Y; Fujii S; Ikeda K; Matsunaga T; Ito Y; Sakamaki S; Niitsu Y
Int J Hematol; 1993 Jun; 57(3):265-8. PubMed ID: 8364189
[TBL] [Abstract][Full Text] [Related]
13. [The morphological, immunophenotypical and cytogenetic characteristics study of blast crisis in chronic myeloid leukemia].
Tang X; Wu D; Xue Y; Zhu M; Lu D; Ruan C
Zhonghua Nei Ke Za Zhi; 2002 Oct; 41(10):685-7. PubMed ID: 12485536
[TBL] [Abstract][Full Text] [Related]
14. Immunophenotype of blast cells in chronic myeloid leukemia.
Valiron O; Clemancey-Marcille G; Troesch A; Schweitzer A; Prenant M; Hollard D; Berthier R
Leuk Res; 1988; 12(10):861-72. PubMed ID: 3199845
[TBL] [Abstract][Full Text] [Related]
15. Immunophenotypic analysis of various blastic crises in chronic myeloid leukemia: correlations between CD7 expression and response to chemotherapy.
Hirose Y; Masaki Y; Shimoyama K; Fukushima T; Kawabata H; Ogawa N; Wano Y; Sugai S
Int J Hematol; 2003 May; 77(4):420-2. PubMed ID: 12774936
[No Abstract] [Full Text] [Related]
16. Mixed phenotype (T/B/myeloid) extramedullary blast crisis as an initial presentation of chronic myelogenous leukemia.
Qing X; Qing A; Ji P; French SW; Mason H
Exp Mol Pathol; 2018 Apr; 104(2):130-133. PubMed ID: 29501750
[TBL] [Abstract][Full Text] [Related]
17. Immunophenotypic and genotypic characteristics of chronic myelogenous leukemia in blast crisis.
Yen CC; Liu JH; Wang WS; Fan FS; Chiou TJ; Tai CJ; Yang MH; Chao TC; Hsiao LT; Chen PM
Zhonghua Yi Xue Za Zhi (Taipei); 2000 Nov; 63(11):785-91. PubMed ID: 11155753
[TBL] [Abstract][Full Text] [Related]
18. [The immunological indices of patients with chronic myeloleukemia at the blast crisis stage].
Romanova AF; Fedorovskaia EA; Pesotskaia LA
Vrach Delo; 1991 Apr; (4):65-7. PubMed ID: 2063572
[TBL] [Abstract][Full Text] [Related]
19. The onset of CML in blastic crisis: molecular features.
Gregorini A; Filippetti A; Luchetti F; Walker A; Lillington DM; Papa S; Valentini M
J Biol Regul Homeost Agents; 1997; 11(3):111-4. PubMed ID: 9498160
[TBL] [Abstract][Full Text] [Related]
20. Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome.
Druker BJ; Sawyers CL; Kantarjian H; Resta DJ; Reese SF; Ford JM; Capdeville R; Talpaz M
N Engl J Med; 2001 Apr; 344(14):1038-42. PubMed ID: 11287973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
